Abstract

Over a hundred years ago, high doses of salicylates were shown to lower glucose levels in diabetic patients. This should have been an important clue to link inflammation to the pathogenesis of type 2 diabetes (T2D), but the antihyperglycemic and antiinflammatory effects of salicylates were not connected to the pathogenesis of insulin resistance until recently. Together with the discovery of an important role for tissue macrophages, these new findings are helping to reshape thinking about how obesity increases the risk for developing T2D and the metabolic syndrome. The evolving concept of insulin resistance and T2D as having immunological components and an improving picture of how inflammation modulates metabolism provide new opportunities for using antiinflammatory strategies to correct the metabolic consequences of excess adiposity.

Keywords

Insulin resistanceInflammationPathogenesisType 2 diabetesMetabolic syndromeObesityDiabetes mellitusInsulinMedicineEndocrinologyBioinformaticsImmunologyInternal medicineBiology

Affiliated Institutions

Related Publications

Publication Info

Year
2006
Type
review
Volume
116
Issue
7
Pages
1793-1801
Citations
4473
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

4473
OpenAlex

Cite This

Steven E. Shoelson, Jongsoon Lee, Allison B. Goldfine (2006). Inflammation and insulin resistance. Journal of Clinical Investigation , 116 (7) , 1793-1801. https://doi.org/10.1172/jci29069

Identifiers

DOI
10.1172/jci29069